JP Patent

JP2004516329A — スルファミドチエノピリミジン

Assigned to Merck Patent GmbH · Expires 2004-06-03 · 22y expired

What this patent protects

本発明は、式Ｉの化合物【化１】式中、Ｒ１、Ｅ２、Ｘは定義したものである、で表される前記化合物に関する。

USPTO Abstract

本発明は、式Ｉの化合物【化１】式中、Ｒ１、Ｅ２、Ｘは定義したものである、で表される前記化合物に関する。

Drugs covered by this patent

Jascayd (NERANDOMILAST) · Boehringer Ingelheim

Patent Metadata

Patent number: JP2004516329A
Jurisdiction: JP
Classification: —
Expires: 2004-06-03
Drug substance claim: No
Drug product claim: No
Assignee: Merck Patent GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.